22 May 2013
Keywords: scolr, pharma, files, provisional, patent, rosiglitazone, firm
Article | 10 January 2005
US firm SCOLR Pharma has filed a provisional patent application with the US Patent and Trademark Office utilizing the company's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2005
© 2013 thepharmaletter.com